Works by Yusuke Kawamura

Results: 215
    1

    Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.

    Published in:
    2017
    By:
    • Shunichiro Fujiyama;
    • Satoshi Saitoh;
    • Yusuke Kawamura;
    • Hitomi Sezaki;
    • Tetsuya Hosaka;
    • Norio Akuta;
    • Masahiro Kobayashi;
    • Yoshiyuki Suzuki;
    • Fumitaka Suzuki;
    • Yasuji Arase;
    • Kenji Ikeda;
    • Hiromitsu Kumada;
    • Fujiyama, Shunichiro;
    • Saitoh, Satoshi;
    • Kawamura, Yusuke;
    • Sezaki, Hitomi;
    • Hosaka, Tetsuya;
    • Akuta, Norio;
    • Kobayashi, Masahiro;
    • Suzuki, Yoshiyuki
    Publication type:
    journal article
    2

    Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma.

    Published in:
    Oncology, 2011, v. 80, n. 3/4, p. 188, doi. 10.1159/000328749
    By:
    • Imai, Norihiro;
    • Ikeda, Kenji;
    • Seko, Yuya;
    • Kawamura, Yusuke;
    • Sezaki, Hitomi;
    • Hosaka, Tetsuya;
    • Akuta, Norio;
    • Kobayashi, Masahiro;
    • Saitoh, Satoshi;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Arase, Yasuji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    3

    Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy.

    Published in:
    Hepatology Research, 2025, v. 55, n. 2, p. 275, doi. 10.1111/hepr.14114
    By:
    • Kawamura, Yusuke;
    • Akuta, Norio;
    • Shindoh, Junichi;
    • Matsumura, Masaru;
    • Okubo, Satoshi;
    • Tominaga, Licht;
    • Yamamoto, Shigeki;
    • Eriksson, Yasuka;
    • Hosaka, Tetsuya;
    • Saitoh, Satoshi;
    • Sezaki, Hitomi;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Ikeda, Kenji;
    • Arase, Yasuji;
    • Hashimoto, Masaji;
    • Kozuka, Takuyo;
    • Kumada, Hiromitsu
    Publication type:
    Article
    4
    5
    6

    Impact of fibrosis on liver‐related event incidence in nonalcoholic fatty liver disease: A multicenter observational study.

    Published in:
    Hepatology Research, 2023, v. 53, n. 12, p. 1169, doi. 10.1111/hepr.13950
    By:
    • Chayama, Kazuaki;
    • Hiramatsu, Akira;
    • Shima, Toshihide;
    • Itoh, Yoshito;
    • Yamaguchi, Kanji;
    • Nakajima, Tomoaki;
    • Hoshikawa, Kyoko;
    • Kawamura, Yusuke;
    • Akuta, Norio;
    • Ito, Kiyoaki;
    • Kawanaka, Miwa;
    • Sakamoto, Michiie;
    • Harada, Kenichi;
    • Goto, Yoshihito;
    • Nakayama, Takeo;
    • Kumada, Hiromitsu;
    • Okanoue, Takeshi
    Publication type:
    Article
    7

    Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors.

    Published in:
    Hepatology Research, 2023, v. 53, n. 7, p. 607, doi. 10.1111/hepr.13897
    By:
    • Akuta, Norio;
    • Kawamura, Yusuke;
    • Fujiyama, Shunichiro;
    • Nakamichi, Kenichi;
    • Saegusa, Eiji;
    • Ogura, Hidetoshi;
    • Kato, Masaki;
    • Doi, Etsuko;
    • Inoue, Naoko;
    • Sezaki, Hitomi;
    • Hosaka, Tetsuya;
    • Kobayashi, Mariko;
    • Saitoh, Satoshi;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Suzuki, Yoshiyuki;
    • Kumada, Hiromitsu;
    • Suzuki, Fumitaka
    Publication type:
    Article
    8

    Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B.

    Published in:
    Hepatology Research, 2022, v. 52, n. 2, p. 153, doi. 10.1111/hepr.13726
    By:
    • Hosaka, Tetsuya;
    • Suzuki, Fumitaka;
    • Kobayashi, Masahiro;
    • Fujiyama, Shunichirou;
    • Kawamura, Yusuke;
    • Sezaki, Hitomi;
    • Akuta, Norio;
    • Suzuki, Yoshiyuki;
    • Saitoh, Satoshi;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kobayashi, Mariko;
    • Kumada, Hiromitsu
    Publication type:
    Article
    9

    Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir.

    Published in:
    Hepatology Research, 2021, v. 51, n. 4, p. 503, doi. 10.1111/hepr.13618
    By:
    • Suzuki, Fumitaka;
    • Sezaki, Hitomi;
    • Hosaka, Tetsuya;
    • Suzuki, Yoshiyuki;
    • Fujiyama, Shunichiro;
    • Kawamura, Yusuke;
    • Akuta, Norio;
    • Kobayashi, Masahiro;
    • Saitoh, Satoshi;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kobayashi, Mariko;
    • Mineta, Rie;
    • Suzuki, Yukiko;
    • Kumada, Hiromitsu
    Publication type:
    Article
    10

    Potential of ultra‐highly sensitive immunoassays for hepatitis B surface and core‐related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

    Published in:
    Hepatology Research, 2021, v. 51, n. 4, p. 426, doi. 10.1111/hepr.13602
    By:
    • Suzuki, Fumitaka;
    • Hosaka, Tetsuya;
    • Imaizumi, Masayasu;
    • Kobayashi, Mariko;
    • Ohue, Chiharu;
    • Suzuki, Yoshiyuki;
    • Fujiyama, Shunichiro;
    • Kawamura, Yusuke;
    • Sezaki, Hitomi;
    • Akuta, Norio;
    • Kobayashi, Masahiro;
    • Saitoh, Satoshi;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    11

    Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease.

    Published in:
    Hepatology Research, 2021, v. 51, n. 1, p. 62, doi. 10.1111/hepr.13572
    By:
    • Ochiai, Yorinari;
    • Kawamura, Yusuke;
    • Kobayashi, Masahiro;
    • Shindoh, Junichi;
    • Kobayashi, Yuta;
    • Okubo, Satoshi;
    • Muraishi, Nozomu;
    • Kajiwara, Akira;
    • Iritani, Soichi;
    • Fujiyama, Shunichiro;
    • Hosaka, Tetsuya;
    • Saitoh, Satoshi;
    • Sezaki, Hitomi;
    • Akuta, Norio;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Ikeda, Kenji;
    • Arase, Yasuji;
    • Hashimoto, Masaji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    12

    Advantage of liver stiffness measurement before and after direct‐acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C.

    Published in:
    Hepatology Research, 2020, v. 50, n. 4, p. 426, doi. 10.1111/hepr.13467
    By:
    • Ogasawara, Nobuhiko;
    • Saitoh, Satoshi;
    • Akuta, Norio;
    • Sezaki, Hitomi;
    • Suzuki, Fumitaka;
    • Fujiyama, Shunichiro;
    • Kawamura, Yusuke;
    • Hosaka, Tetsuya;
    • Kobayashi, Masahiro;
    • Suzuki, Yoshiyuki;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    13

    Long‐term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus‐related liver cirrhosis after interferon‐based therapy.

    Published in:
    Hepatology Research, 2019, v. 49, n. 12, p. 1441, doi. 10.1111/hepr.13418
    By:
    • Ogasawara, Nobuhiko;
    • Saitoh, Satoshi;
    • Akuta, Norio;
    • Fujiyama, Shunichiro;
    • Kawamura, Yusuke;
    • Sezaki, Hitomi;
    • Hosaka, Tetsuya;
    • Kobayashi, Masahiro;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    14
    15

    Primary liver carcinoma with sarcomatous changes: Analysis of 10 cases.

    Published in:
    Hepatology Research, 2019, v. 49, n. 6, p. 711, doi. 10.1111/hepr.13295
    By:
    • Ohya, Kazuki;
    • Saitoh, Satoshi;
    • Fujiyama, Shunichiro;
    • Kawamura, Yusuke;
    • Sezaki, Hitomi;
    • Hosaka, Tetsuya;
    • Akuta, Norio;
    • Kobayashi, Masahiro;
    • Kobayashi, Mariko;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kinowaki, Keiichi;
    • Fujii, Takeshi;
    • Kondo, Fukuo;
    • Kumada, Hiromitsu
    Publication type:
    Article
    16

    Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non‐alcoholic fatty liver disease complicated by diabetes mellitus.

    Published in:
    Hepatology Research, 2019, v. 49, n. 5, p. 531, doi. 10.1111/hepr.13304
    By:
    • Akuta, Norio;
    • Kawamura, Yusuke;
    • Watanabe, Chizuru;
    • Nishimura, Akihiro;
    • Okubo, Minoru;
    • Mori, Yasumichi;
    • Fujiyama, Shunichiro;
    • Sezaki, Hitomi;
    • Hosaka, Tetsuya;
    • Kobayashi, Masahiro;
    • Kobayashi, Mariko;
    • Saitoh, Satoshi;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    17
    18

    No‐touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection.

    Published in:
    Hepatology Research, 2019, v. 49, n. 2, p. 164, doi. 10.1111/hepr.13254
    By:
    • Kawamura, Yusuke;
    • Ikeda, Kenji;
    • Shindoh, Junichi;
    • Kobayashi, Yuta;
    • Kasuya, Kayoko;
    • Fujiyama, Shunichiro;
    • Hosaka, Tetsuya;
    • Kobayashi, Masahiro;
    • Saitoh, Satoshi;
    • Sezaki, Hitomi;
    • Akuta, Norio;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Arase, Yasuji;
    • Hashimoto, Masaji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26

    Efficacy of the Combination of Systemic Sequential Therapy and Locoregional Therapy in the Long-Term Survival of Patients with BCLC Stage C Hepatocellular Carcinoma.

    Published in:
    Cancers, 2023, v. 15, n. 15, p. 3789, doi. 10.3390/cancers15153789
    By:
    • Kawamura, Yusuke;
    • Akuta, Norio;
    • Shindoh, Junichi;
    • Matsumura, Masaru;
    • Okubo, Satoshi;
    • Tominaga, Licht;
    • Fujiyama, Shunichiro;
    • Hosaka, Tetsuya;
    • Saitoh, Satoshi;
    • Sezaki, Hitomi;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Ikeda, Kenji;
    • Arase, Yasuji;
    • Hashimoto, Masaji;
    • Kozuka, Takuyo;
    • Kumada, Hiromitsu
    Publication type:
    Article
    27
    28

    Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May Be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment.

    Published in:
    Internal Medicine, 2022, v. 61, n. 7, p. 951, doi. 10.2169/internalmedicine.7589-21
    By:
    • Nozomu Muraishi;
    • Yusuke Kawamura;
    • Masahiro Kobayashi;
    • Junichi Shindoh;
    • Yuta Kobayashi;
    • Satoshi Okubo;
    • Soichi Iritani;
    • Shunichiro Fujiyama;
    • Tetsuya Hosaka;
    • Satoshi Saitoh;
    • Hitomi Sezaki;
    • Norio Akuta;
    • Fumitaka Suzuki;
    • Yoshiyuki Suzuki;
    • Kenji Ikeda;
    • Yasuji Arase;
    • Masaji Hashimoto;
    • Ichiro Yasuda;
    • Hiromitsu Kumada
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Clinical and virological effects of long-term (over 5 years) lamivudine therapy.

    Published in:
    Journal of Medical Virology, 2010, v. 82, n. 4, p. 684, doi. 10.1002/jmv.21681
    By:
    • Hashimoto, Yoshimasa;
    • Suzuki, Fumitaka;
    • Hirakawa, Miharu;
    • Kawamura, Yusuke;
    • Yatsuji, Hiromi;
    • Sezaki, Hitomi;
    • Hosaka, Tetuya;
    • Akuta, Norio;
    • Kobayashi, Masahiro;
    • Saito, Satoshi;
    • Suzuki, Yoshiyuki;
    • Kobayashi, Mariko;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    39

    Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.

    Published in:
    Journal of Medical Virology, 2010, v. 82, n. 4, p. 575, doi. 10.1002/jmv.21741
    By:
    • Akuta, Norio;
    • Suzuki, Fumitaka;
    • Hirakawa, Miharu;
    • Kawamura, Yusuke;
    • Yatsuji, Hiromi;
    • Sezaki, Hitomi;
    • Suzuki, Yoshiyuki;
    • Hosaka, Tetsuya;
    • Kobayashi, Masahiro;
    • Kobayashi, Mariko;
    • Saitoh, Satoshi;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    40

    Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.

    Published in:
    Journal of Medical Virology, 2010, v. 82, n. 3, p. 390, doi. 10.1002/jmv.21691
    By:
    • Arase, Yasuji;
    • Suzuki, Fumitaka;
    • Suzuki, Yoshiyuki;
    • Akuta, Norio;
    • Kobayashi, Masahiro;
    • Sezaki, Hitomi;
    • Hosaka, Tetsuya;
    • Kawamura, Yusuke;
    • Yatsuji, Hiromi;
    • Hirakawa, Miharu;
    • Ikeda, Kenji;
    • Hsieh, Shiun Dong;
    • Oomoto, Yuki;
    • Amakawa, Kazuhisa;
    • Kato, Hisahito;
    • Kazawa, Tamae;
    • Tsuji, Hiroshi;
    • Kobayashi, Tetsuro;
    • Kumada, Hiromitsu
    Publication type:
    Article
    41
    42

    Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.

    Published in:
    Journal of Medical Virology, 2009, v. 81, n. 6, p. 1032, doi. 10.1002/jmv.21473
    By:
    • Akuta, Norio;
    • Suzuki, Fumitaka;
    • Hirakawa, Miharu;
    • Kawamura, Yusuke;
    • Yatsuji, Hiromi;
    • Sezaki, Hitomi;
    • Suzuki, Yoshiyuki;
    • Hosaka, Tetsuya;
    • Kobayashi, Masahiro;
    • Kobayashi, Mariko;
    • Saitoh, Satoshi;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    43

    A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response.

    Published in:
    Journal of Medical Virology, 2009, v. 81, n. 3, p. 452, doi. 10.1002/jmv.21400
    By:
    • Akuta, Norio;
    • Suzuki, Fumitaka;
    • Hirakawa, Miharu;
    • Kawamura, Yusuke;
    • Yatsuji, Hiromi;
    • Sezaki, Hitomi;
    • Suzuki, Yoshiyuki;
    • Hosaka, Tetsuya;
    • Kobayashi, Masahiro;
    • Kobayashi, Mariko;
    • Saitoh, Satoshi;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    44
    45

    Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.

    Published in:
    Journal of Medical Virology, 2008, v. 80, n. 8, p. 1363, doi. 10.1002/jmv.21224
    By:
    • Akuta, Norio;
    • Suzuki, Fumitaka;
    • Kawamura, Yusuke;
    • Yatsuji, Hiromi;
    • Sezaki, Hitomi;
    • Suzuki, Yoshiyuki;
    • Hosaka, Tetsuya;
    • Kobayashi, Masahiro;
    • Kobayashi, Mariko;
    • Arase, Yasuji;
    • Ikeda, Kenji;
    • Kumada, Hiromitsu
    Publication type:
    Article
    46
    47
    48
    49
    50